• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿5-羟吲哚乙酸升高的发生率。

The incidence of elevations in urine 5-hydroxyindoleacetic acid.

作者信息

Nuttall K L, Pingree S S

机构信息

Department of Pathology, University of Utah School of Medicine, Salt Lake City 84132, USA.

出版信息

Ann Clin Lab Sci. 1998 May-Jun;28(3):167-74.

PMID:9646859
Abstract

A 24-hour urine collection for 5-hydroxyindoleacetic acid (HIAA) is commonly performed to evaluate patients with suspected carcinoid syndrome. However, carcinoids are rare, and elevated results are common even when using an analytically specific method. To characterize this problem, the incidence of elevated results was examined in a population of 947 patient specimens received in a clinical reference laboratory setting. Using a reference limit of 15 mg/d identified 7.9 percent of the results as elevated, with 3 percent > 100 mg/d, and about 1 percent > 350 mg/d. Males showed 14 percent > 15 mg/d compared to 5.2 percent for females. Characterization of incomplete and excess 24-hr urine collections is facilitated by use of a creatinine ratio, with a reference limit of 14 mg/g creatinine equivalent to 15 mg/d. Given the frequency of elevated results, HIAA should be used to support the diagnoses of carcinoid only when consistent with other objective findings.

摘要

通常会进行24小时尿5-羟吲哚乙酸(HIAA)检测,以评估疑似类癌综合征的患者。然而,类癌较为罕见,即便采用分析特异性方法,检测结果升高的情况也很常见。为了明确这一问题,我们在临床参考实验室环境下,对947份患者样本进行检测,以检查结果升高的发生率。采用15mg/d的参考限值,7.9%的结果被判定为升高,其中3%大于100mg/d,约1%大于350mg/d。男性结果大于15mg/d的比例为14%,而女性为5.2%。使用肌酐比值有助于判断24小时尿液收集是否完整或过量,参考限值为14mg/g肌酐相当于15mg/d。鉴于结果升高的频率,仅当HIAA检测结果与其他客观发现一致时,才可用于辅助类癌的诊断。

相似文献

1
The incidence of elevations in urine 5-hydroxyindoleacetic acid.尿5-羟吲哚乙酸升高的发生率。
Ann Clin Lab Sci. 1998 May-Jun;28(3):167-74.
2
Measurement of the 5-hydroxyindoleacetic acid/creatinine ration in the urine of patients with coeliac disease.乳糜泻患者尿液中5-羟吲哚乙酸/肌酐比值的测定。
Hepatogastroenterology. 1981 Jun;28(3):160-2.
3
'Sweet Dreams', 'Happy Days' and elevated 24-h urine 5-hydroxyindoleacetic acid excretion.“美梦”、“快乐时光”和升高的 24 小时尿液 5-羟色氨酸排泄。
Ann Clin Biochem. 2013 Jan;50(Pt 1):80-2. doi: 10.1258/acb.2012.012041. Epub 2012 Oct 19.
4
Biochemical assessment of niacin deficiency among carcinoid cancer patients.类癌患者烟酸缺乏的生化评估
Am J Gastroenterol. 2005 Oct;100(10):2307-14. doi: 10.1111/j.1572-0241.2005.00268.x.
5
[The syndrome of metastazing carcinoid. 3. Long-term follow up of 5-hydroxyindoleacetic acid excretion in the urine].[转移性类癌综合征。3. 尿中5-羟吲哚乙酸排泄的长期随访]
Cas Lek Cesk. 1968 Mar;107(13):394-8.
6
[Excretion of 5-hydroxyindoleacetic acid in carcinoid syndrome].[类癌综合征中5-羟吲哚乙酸的排泄]
Z Gesamte Inn Med. 1968 Sep 15;23(18):553-6.
7
Normal 5-hydroxyindole excretion in the presence of carcinoid syndrome.类癌综合征患者的正常5-羟色胺排泄情况。
Ir Med J. 1987 Apr;80(4):122-3.
8
[Laboratory findings in the carcinoid syndrome].[类癌综合征的实验室检查结果]
Dtsch Med Wochenschr. 1968 May 10;93(19):959-61. doi: 10.1055/s-0028-1105173.
9
[Treatment of carcinoid syndrome with ocreotide (SMS-201-995)].用奥曲肽(SMS-201-995)治疗类癌综合征
Rev Clin Esp. 1992 Jul;191(3):168.
10
Spot urine 5-hydroxy indole acetic acid and acute appendicitis.随机尿5-羟吲哚乙酸与急性阑尾炎
Hepatogastroenterology. 2001 May-Jun;48(39):609-13.

引用本文的文献

1
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption.欧洲吸收不良共识 - 欧洲胃肠病学联合会(UEG)与意大利胃肠病学、肝脏病学和消化内镜学会(SIGE)、拉丁美洲胃肠病学联合会(LGA)、西班牙胃肠病学协会(SPG)、瑞士胃肠病学和肝病学会(SRGH)、克罗地亚胃肠病学会(CGS)、欧洲儿科胃肠病学和营养学会(ESPCG)、欧洲老年胃肠病学网络(EAGEN)、欧洲临床营养和代谢学会(ESPEN)以及欧洲儿科胃肠病学、肝病学和营养学会(ESPGHAN)。第1部分:吸收不良的定义、临床表型及诊断检测
United European Gastroenterol J. 2025 May;13(4):599-613. doi: 10.1002/ueg2.70012. Epub 2025 Mar 25.
2
Biomarkers selection for population normalization in SARS-CoV-2 wastewater-based epidemiology.基于 SARS-CoV-2 污水流行病学的人群校正生物标志物选择。
Water Res. 2022 Sep 1;223:118985. doi: 10.1016/j.watres.2022.118985. Epub 2022 Aug 15.
3
Biomarkers Selection for Population Normalization in SARS-CoV-2 Wastewater-based Epidemiology.用于新冠病毒污水流行病学中人群标准化的生物标志物选择
medRxiv. 2022 Mar 15:2022.03.14.22272359. doi: 10.1101/2022.03.14.22272359.
4
Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.结直肠神经内分泌肿瘤的临床病理特征及生物标志物
PLoS One. 2017 Dec 12;12(12):e0188876. doi: 10.1371/journal.pone.0188876. eCollection 2017.